The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:

Notices

• Request for Information on the Development of the FY 2019 Trans-NIH Plan for HIV-Related Research
  Office of AIDS Research
   
• Notice of Correction for RFA-OD-17-002 "Center for Coordination of Analytics, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54)"
  National Institutes of Health
  Office of Disease Prevention
   
• Notice of Correction for RFA-OD-17-006 "Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54)"
  National Institutes of Health
  Office of Disease Prevention
   
• Guidance for Adjustments to Appointment Records in xTrain to Reflect Stipend Level Increases for Postdoctoral Trainees on Institutional Ruth L. Kirschstein National Research Service Awards (NRSA)
  National Institutes of Health
   
• Notice of Form Correction for PA-16-286 "Successor-in-Interest (Type 6 Parent)"
  National Institutes of Health
   
• Notice of Intent to Publish a Funding Opportunity Announcement for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers Research Centers (P50)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Heart, Lung, and Blood Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
   
• Notice of Intent to Publish a Funding Opportunity Announcement for Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
   
• Notice of Informational Webinars for Investigators Applying for NCCIH Clinical Trials
  National Center for Complementary and Integrative Health
   
• Notice of Change to Key Dates in PAR-16-111 "Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01)"
  National Cancer Institute
   
• Notice of Pre-application Webinar for PAR-16-131 Emerging Questions in Cancer Systems Biology (U01)
  National Cancer Institute
   
• Notice of Change in the Expiration Date for PA-14-162 "Effects of Cannabis Use and Cannabinoids on the Developing Brain (R21)"
  National Institute on Drug Abuse
   
• Notice of Change in the Expiration Date for PA-14-164 "Effects of Cannabis Use and Cannabinoids on the Developing Brain (R03)"
  National Institute on Drug Abuse
   
• Notice of Change in the Expiration Date for PA-14-163 "Effects of Cannabis Use and Cannabinoids on the Developing Brain (R01)"
  National Institute on Drug Abuse
   
• Notice of Change in the Expiration Date for PA-14-083 "Neuroimmune Signaling and Function in Substance Use Disorders (R21)"
  National Institute on Drug Abuse
   
• Notice of Change in the Expiration Date for PA-14-084 "Neuroimmune Signaling and Function in Substance Use Disorders (R01)"
  National Institute on Drug Abuse
   
• Notice of Change in the Expiration Date for PAR-14-225 Clinical Evaluation of Adjuncts to Opioid Therapies for the Treatment of Chronic Pain (R01)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Cancer Institute
   
• Notice of Change in the Expiration Date for PA-15-099 "Reductions in Illicit Drug Use and Functional Outcomes (R21/R33)"
  National Institute on Drug Abuse
   
• RFP Notice: Pharmacokinetic and Pharmacodynamic Studies for Medications Development
  National Institute on Drug Abuse
   
• Notice to Extend PAR-15-024 "Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01)
  National Institute of Diabetes and Digestive and Kidney Diseases
   
• Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) (U18)
  Food and Drug Administration
   
• Notice of NICHD's Participation in PAR-17-221 "Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25)"
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
   
• Correction for AHRQ Consumer Assessment of Healthcare Providers and Systems V (U18) FOA
  Agency for Healthcare Research and Quality
   
• Request for Information (RFI): Input on Opportunities of Engagement of External Stakeholders With the Illuminating the Druggable Genome (IDG) Program
  NIH Roadmap Initiatives

Requests for Applications

• Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
   
• SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44)
  National Cancer Institute
   
• Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33)
  National Institute on Drug Abuse
• Identification of Reproductive-Tract Specific Proteins/Transcripts for the Development of Male and Female Non-Hormonal Contraceptives (R01)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
• Point of Care Technologies for the Evaluation and Management of Obstetrics, Neonatal, and Pediatric Critical Care Patients, and for Patients with Disorders of Reproductive Tract and Infertility (R43)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
   
• Integrative Computational Biology for Analysis of NHLBI TOPMed Data
  National Heart, Lung, and Blood Institute
   
• Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT2)
  NIH Roadmap Initiatives
  National Center for Advancing Translational Sciences
  The Common Fund/Office of Strategic Coordination
   

Program Announcements

• NINDS Program Project Grant (P01)
  National Institute of Neurological Disorders and Stroke.
• From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative R01)
• From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (R01)
  National Institute of Mental Health
   
• Lasker Clinical Research Scholars Program Si2/R00
  National Institutes of Health
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
   
• Collaborative R01s for Clinical Studies of Mental Illness Not Involving Clinical Trials (Collaborative R01)
  National Institute of Mental Health

Details, including application deadlines, when applicable, are available through the program links above.  To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Linda Meyer at linda-k-meyer@uiowa.edu, Paul Below at paul-below@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu